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a  b  s  t  r  a  c  t
The  use  of  endovascular  catheters  is  a  routine  practice  in  secondary  and  tertiary  care  level  hospitals.  The
short-term  use  of  peripheral  catheters  has  been  found  to  be associated  with  the  risk  of  nosocomial  bacter-
aemia,  resulting  in  morbidity  and  mortality.  Staphylococcus  aureus  is mostly  associated  with  peripheral
catheter  insertion.  This  Consensus  Document  has  been  prepared  by  a panel  of  experts  of  the Spanish
Society  of Cardiovascular  Infections,  in  cooperation  with  experts  from  the  Spanish  Society  of  Internal
Medicine,  Spanish  Society  of Chemotherapy,  and the  Spanish  Society  of  Thoracic-Cardiovascular  Surgery,
and aims  to  deﬁne  and  establish  guidelines  for  the  management  of  short  duration  peripheral  vascular
catheters.  The  document  addresses  the  indications  for insertion,  catheter  maintenance,  registering,  diag-
nosis and  treatment  of infection,  indications  for removal,  as well  as  placing  an  emphasis  on  continuous
education  as  a drive  toward  quality.  Implementation  of  these  guidelines  will  allow  uniformity  in  use,
thus minimizing  the  risk  of infections  and  their  complications.
© 2016  Published  by  Elsevier  Espan˜a,  S.L.U.  on  behalf  of Sociedad  Espan˜ola  de  Cirugı´a
Tora´cica-Cardiovascular.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Documento  de  Consenso  de  2016  sobre  la  prevención,  diagnóstico
y  tratamiento  de  las  infecciones  por  catéter  venoso  periférico  en  adultosalabras clave:
nfección de catéter
atéter venoso periférico
r  e  s  u  m  e  n
El  uso de  catéteres  vasculares  es una  práctica  muy  utilizada  en  los  hospitales.  El  uso  de  catéteres  venosos
periféricos  de  corta  duración  se ha  asociado  con un  elevado  riesgo  de  bacteriemia  nosocomial,  lo que
comporta  una  no despreciable  morbilidad  y  mortalidad.  La  etiología  de  estas  infecciones  suele ser
Abbreviations: SEICAV, Sociedad Espan˜ola de Infecciones Cardiovasculares; SEMI, Sociedad Espan˜ola de Medicina Interna; SEQ, Sociedad Espan˜ola de Quimioterapia;
ECTCV, Sociedad Espan˜ola de Cirugia Torácica-Cardiovascular; PVC, peripheral venous catheter; ICU, Intensive Care Unit; NCBI, National Center for Biotechnology Information;
LM,  National Library of Medicine; PICC, peripherally-inserted central catheters; ISDA, Infectious Disease Society of America.
Abreviaturas: SEICAV, Sociedad Espan˜ola de Infecciones Cardiovasculares; SEMI, Sociedad Espan˜ola de Medicina Interna; SEQ, Sociedad Espan˜ola de Quimioterapia;
ECTCV, Sociedad Espan˜ola de Cirugia Torácica-Cardiovascular; PVC, Peripheral venous catheter; ICU, Intensive Care Unit; NCBI, National Center for Biotechnology Information;
LM,  National Library of Medicine; PICC, Peripherally-inserted central catheters; ISDA, Infectious Disease Society of America.
 This article has also been published in Rev Esp Quimioter 2016;29(4).
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icense  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Prevención de la infección de catéter
Diagnóstico de la infección de catéter
Tratamiento de la infección de catèter
frecuentemente  por  Staphylococcus  aureus,  lo que  explica  su  gravedad.  En  este  documento  de  consenso,
elaborado  por  un  panel  de expertos  de la  Sociedad  Espan˜ola  de  Infecciones  Cardiovasculares  con la  cola-
boración  de expertos  de  la  Sociedad  Espan˜ola  de  Medicina  Interna,  la Sociedad  Espan˜ola  de  Quimioter-
apia y la Sociedad  Espan˜ola  de  Cirugía  Torácica-Cardiovascular,  pretende  establecer  unes  normas  para
un  mejor  uso  de  los  catéteres  venosos  periféricos  de  corta  duración.  El  Documento  revisa  las  indica-
ciones  para  su  inserción,  mantenimiento,  registro,  diagnóstico  y  tratamiento  de las  infecciones  derivadas
y  las indicaciones  para  su retirada;  haciendo  énfasis  en  la  formación  continuada  del  personal  sanitario
para lograr  una  mayor  calidad  asistencial.  Seguir  las recomendaciones  del consenso  permitirá  utilizar  de
una  manera  más  homogénea  los  catéteres  venosos  periféricos  minimizando  el  riesgo  de  infección  y sus
complicaciones.
©  2016  Publicado  por Elsevier  Espan˜a,  S.L.U.  en  nombre  de  Sociedad  Espan˜ola  de  Cirugı´a
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Table 1 describes the levels of evidence and the strength of rec-
ommendations according to the criteria of the Infectious Disease
Society of America (ISDA).15
PVC is a catheter shorter than 7.62 cm (3 in.).
Table 1
Infectious Disease Society of America – United States Public Health Service Grading
System for ranking recommendations in clinical guidelines.15
Category, grade Deﬁnition
Strength of recommendation
A Good evidence to support a recommendation
for use
B  Moderate evidence to support a
recommendation for use
C  Poor evidence to support a recommendation
D  Moderate evidence to support a
recommendation against use
E  Good evidence to support a recommendation
against use
Quality of evidence
I  Evidence from >1 properly randomized,
controlled trial
II  Evidence from >1 well-designed clinical trial,
without randomization; from cohort or
case-controlled analytic studies (preferably
from >1 center); from multiple time-series; or
from dramatic results from uncontrolled
experiments
III Evidence from opinions of respectedTora´cica-Cardio
ackground
The use of endovascular catheters is generalized practice in the
ospital setting.1 A recent prevalence study showed that 81.9%
f patients admitted to Internal Medicine services are inserted
ith one or more catheters, out of which 95.4% are short dura-
ion peripheral lines.2 It has also recently been documented the
ncreasing inﬂuence of peripheral catheters as a driver for nosoco-
ial bacteremia with high associated morbidity and mortality.3–5
everal studies have shown that the risk of bacteremia related
o a peripheral venous catheter (PVC) is similar to that of cen-
ral venous lines6 with an estimate of 0–5 bacteremia episodes
er 1000 catheter-days in admitted adult patients.4,6 Further-
ore, the vast majority of cases of PVC-related bacteremia are S.
ureus bacteremia; this is different from central venous lines, being
. epidermidis the most frequent isolated pathogen in the latter
etting.3,4 This yields a higher complication rate including nosoco-
ial endocarditis thus making treatment difﬁcult. There are several
uidelines and consensus documents on prevention, diagnosis and
reatment of central venous catheter-related infections7–10 that
ave greatly contributed to reduce the infection rate and facilitate
ts management, especially in Intensive Care Units (ICU). However,
here is scanty literature focusing on short duration peripheral
atheters which are those mostly used out of the ICU setting.1,11
everal observational studies have shown that there is lack of
nowledge on how to use PVC by the attending staff12 and on the
pportunities to improve its handling.1,12–14
bjective
The objective of this Consensus Document is to review evidence
nd make recommendations for management of short duration PVC
n adults. This will allow uniformity in usage thus minimizing the
isk of infection and its complications.
articipating organizations
This Consensus Document has been elaborated by a panel
f experts of the Spanish Society of Cardiovascular Infections
SEICAV) in cooperation with experts from the following scien-
iﬁc societies: Spanish Society of Internal Medicine (SEMI), Spanish
ociety of Chemotherapy (SEQ) and Spanish Society of Thoracic-
ardiovascular Surgery (SECTCV).
ethods
The recommendations for insertion, handling and removal of
VCs and also what to do when suspecting infection (diagnosis)
nd its treatment are issued based on the best scientiﬁc avail-
ble evidence or, when not available, on expert opinion. Therefore,
ubMed (www.PubMed.org) literature search between 1986 andlar.  Este  es un  artı´culo  Open  Access  bajo  la  licencia  CC BY-NC-ND  (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
2015 has been performed. This is a well-known free access resource
established and maintained by the National Center for Biotechnol-
ogy Information (NCBI) of the National Library of Medicine (NLM)
of the USA, which provides free access to MEDLINE, the database
of citations and abstracts of the NLM. It currently stores over
24 million citations from over 5600 biomedical journals.
In our PubMed search using the Medical Subject Head-
ings (MeSH) terms “management of peripheral venous catheter”
(N = 363) and “peripheral catheter-related bacteremia” (N = 260),
studies related to newborns or pediatric patients and studies
on peripherally inserted central catheters (PICC) were discarded.
MeSH terms is the NLM controlled vocabulary thesaurus used for
indexing articles for PubMed (www.pubmed.org). Guidelines on
prevention, diagnosis and treatment of catheter infection were
reviewed.7–10
The levels of evidence and strength of recommendations accord-
ing to the below deﬁnitions will be shown in bold within brackets
when a recommendation is made in the text.
Deﬁnitionsauthorities, based on clinical experience,
descriptive studies, or reports of expert
committees
1 Cardiov. 2016;23(4):192–198
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Table 2
Checklist for an appropriate manipulation of peripheral catheters. If these are not
fulﬁlled, the prompt removal of the catheter is advised (Evidence A).
-Insertion
- Correct hand hygiene
- Field disinfection
-  Use single-use clean gloves
-  Do not touch the insertion site
- Do not touch the endovenous segment of the catheter
-  Sterile dressing (gauze or transparent)
-Manipulation
- Daily assessment of the need for the PVC
-  Daily inspection of the insertion site
-  Daily assessment of the function of the catheter
- Adequate replacement of infusion sets
-Catheter and events registry
-  Fluid extravasation
- Presence of blood94 J.A. Capdevila et al. / Cir 
Sepsis is a systemic inﬂammatory response syndrome sec-
ndary to an infection.16 The term phlebitis is used if one of the
ollowing criteria was fulﬁlled: swelling and erythema >4 mm,  ten-
erness, palpable venous cord, pain or fever with local symptoms.
solated swelling is not deﬁned as phlebitis.
nsertion
hen?
PVC will be inserted when the duration of a given endovenous
herapy is expected to be shorter than 6 days and the PVC will
ot be used for major procedures as hemodialysis, plasmapheresis,
hemotherapy, parenteral nutrition, monitoring or administration
f ﬂuid large volumes. When any of these circumstances is to be
xpected, it is preferable to insert a single-, double- or triple-lumen
entral venous line (peripherally inserted or not) as the risk of
hemical phlebitis, the need for high-speed volume infusion or fre-
uent manipulations do not support a short catheter (I-A).17,18 An
solated transfusion does not need a central venous line insertion.
efore placing any venous line, even peripheral, it is mandatory the
valuation of the actual need. Venous lines are often placed as rou-
ine; this meant to be an act reﬂecting the provision of care. It is also
requently shown that to treat the patient a “prophylactic” line was
ot mandatory. A study showed that up to 35% of peripheral venous
ines place in the emergency department are unnecessary.19
here?
A PVC can be inserted in every accessible vein. However, upper
xtremity veins are preferable for patient comfort and lesser risk
f contamination. Some studies reported a higher risk of phlebitis
fter lines were placed at the cubital crease, thus becoming prefer-
ble avoiding this site in beneﬁt of arm, forearm or dorsal aspect of
he hand/wrist20,21 (II-A).
Furthermore, other patient-related factors like accessibility to
he venous system or comfort after insertion have to be taken into
ccount. It does not make much sense to insert a PVC onto a central
ein (III-A).
ow?
The insertion of PVC must be performed under maximal aseptic
echniques. It is not necessary to prep a surgical ﬁeld as it is the
hen inserting a central venous line. The skin must be disinfected
ith 2% alcoholic chlorhexidine solution or, if not available, with a
0% iodine or alcohol solution9,22,23 (I-A).
The insertion site should not be touched after disinfection. The
atheter must be handled from its proximal end when inserted.
he caregiver inserting the PVC must previously perform hand
ygiene with water and soap and/or wash hands with alcohol
olution. Single-use clean gloves must be used. An enhanced asep-
is is not required if the endovenous segment of the PVC is not
anipulated9 (III-B). As it is the case when inserting central venous
ines, the use of additional protection measures like facemask is not
ecommended. However, this is a topic for consideration and analy-
is if in a given institution higher than expected rates of PVC-related
acteremia are observed.
Sterile gauze dressing or semi permeable transparent sterile
ressing to cover the insertion site will be used23,24 (II-A). Ster-
le gauze dressing will be inspected and replaced every other day
nd transparent dressing should not stay in place over 7 days.9 If
here is humidity, sweating or blood it is more appropriate to use
on-occlusive gauze dressing24,25 (III-B). Revision or replacement
f dressing must be performed with single-use clean gloves.9- Inﬂammatory signs
- Dressing status
PVCs placed on urgent basis or without considering minimal
hygiene rules must be removed and replaced before 48 h to avoid
the risk of infection17,26,27 (II-A).
The use of techniques facilitating identiﬁcation of veins as laser
or ultrasound28,29 in patients with poor venous ﬂow are also rec-
ommended for insertion. However, these techniques do not reduce
the risk of infection. A meta-analysis on this topic showed that its
routine use is not justiﬁed30 (I-A).
Checklist
The adhesion to recommendations in the form of checklist is
associated to better results in prevention of post-insertion compli-
cations after insertion of central venous lines and PVCs10,31 (I-A).
This is reﬂected in Table 2.
Maintenance
The catheter and the need for usage have to be assessed daily.
It is advisable to remove the PVC if it is not necessary as the risk of
infection or phlebitis gradually increases as PVC days go by18,32,33
(II-A). It is advisable to insert new PVC, if required, than keeping in
place an inactive line that might be useful at later stage.
The status of the insertion site must also be assessed daily,
seeking for eventual discomfort/symptoms at the endovascular
segment suggesting early stages of phlebitis and checking its func-
tional status. Phlebitis should be suspected if any of the following
signs develop: warmth, tenderness, erythema or palpable cord. In
an abnormality at the insertion site is detected, dressing must be
removed and the site inspected34,35 (III-A). The catheter must then
be removed and its tip sent for Microbiology according to the cri-
terion of the attending physician17 (III-A).
No antiseptic cream shall be used at the insertion point36 (III-C).
Every manipulation of the catheter must be performed with
single-use clean gloves. There is no consensus on the type of con-
nectors to be used. It is preferable a three-way stopcock than caps
requiring connection-disconnection after every use. Closed connec-
tors for catheter access can be used as long as they are disinfected
with alcohol-impregnated wipes at every attempt to access the
catheter37 (II-A).
A meta-analysis revealed that there are no advantages of replac-
ing the infusion system earlier than 96 h38,39 (I-A) other when they
are used for blood transfusion or infusion of lipid emulsions (should
this be the case, they have to be replaced every time). There is no
evidence that neither antibiotic prophylaxis at insertion nor the
antibiotic-lock are cost-efﬁcient to keep PVC free from infection.
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egistry
It is mandatory to keep daily record of characteristics and condi-
ions of the catheter. In this registry the type of catheter, insertion
ate, anatomic location, daily inspection of dressing, removal date
nd cause of removal (malfunction, infection, not required, . . .)
ust be recorded (III-A). The lack of a registry is synonymous of
ack of knowledge on how to use catheters, their complications and
he inability to establish corrective measurements should an event
ccur.40 These registries should ideally be electronically supported
o facilitated data collection and analysis.
emoval
hen?
As there is a causal relationship between the duration of PVC
nd the risk of phlebitis, the need for systematic replacement of
VC at a given time interval to avoid local and systemic complica-
ions has been proposed.18,41,42 However, this strategy may  render
xpensive the provision of care by increasing in over 25% the cost
nd number of catheters to use and make the catheter resite more
ifﬁcult.42,43 This, on the other side, has not avoided the complica-
ions of the use of the new catheter regardless of the inconveniences
f replacing a line for the patient and caregiver.
More recently, prospective and randomized studies comparing
ystematic replacement at 72 h versus clinically indicated replace-
ent of PVC did not found statistically signiﬁcant differences in
he incidence of phlebitis/local infection/bacteremia and the num-
er of malfunctioning catheters both in hospitalized patients and in
atients on home therapy.18,41–51 These observations support the
eplacement of PVC only when indicated (I-A).
Systematic removal of PVC after 3–4 days is not supported,
lthough it is not advised to keep PVC in place beyond 5 days (III-B).
Although keeping in place an unused catheter increases the risk
f phlebitis,51 it is not clear if they must be rinsed with normal saline
r heparin. It seems that the risk of phlebitis is reduced with heparin
ut it continues to be at 45%,52 thus being removal advisable if
nused. Therefore, unused catheters should not be kept in place as
he risk of inﬂammation and infection increases10,53–55 (I-A).
PVC must be removed if the following circumstances apply: end
f therapy, signs of chemical phlebitis, malfunction, suspicion of
nfection or suspicion of inappropriate insertion or manipulation
s in cases of vital emergency56,57 (II-A).
ow?
Simple removal will be performed with single-use clean gloves
nd gauze dressing applied thereafter. Removal for suspected infec-
ion implies sending the tip of the catheter (2–3 mm of distal end)
n a sterile container for Microbiology. In the latter case, single-use
terile gloves and sterile instrument to cut the tip of the PVC must
e used. Only catheters with suspected infection must be sent for
icrobiology (III-A). There will be suspected infection if fever or
igns of sepsis without evident focus and/or suppurated phlebitis
ppeared. Chemical phlebitis alone is not enough to submit the
atheter for Microbiology. It has to be reminded that catheter-
elated bacteremia may  develop without any suspicion that the
atheter may  be the cause.8,58
iagnosisPVC infection shall be suspected when a patient with one or
ore PVC develops fever and/or signs of sepsis without additional
linical focus. Under this circumstance, past history of inappropri-
te manipulation and prolonged duration support a PVC-suspectedv. 2016;23(4):192–198 195
origin of infection. Septic phlebitis or suppuration at the inser-
tion site support this hypothesis58,59; however simple chemical
phlebitis may  cause low-grade fever.
If infection is suspected, 2–3 samples for blood culture must
be collected. Sampling from PVC must be performed under aseptic
conditions. A cotton swab should be used to take samples from
purulent exudate if present. As PVCs should be of short duration
and of easy replacement it is not justiﬁed to keep a catheter in situ
while awaiting results from Microbiology if infection is suspected
(III-B). We  then believe that conservative diagnostic techniques for
diagnosis of infection are not applicable60,61 (III-A). Gram stain of
a PVC segment may  quickly draw the attention on the possibility
of infection.62
Treatment
In the treatment of PVC infection, the ﬁrst step is removal of the
PVC as it has been mentioned above. Once the PVC is removed and
blood samples taken for culture, the need for empirical antibiotic
treatment will be related to the clinical condition of the patient
(including fever and elevation of biomarkers). Treatment should
be directed to PVC bacteremia. Isolated positive tips cultures do
not need antibiotic treatment.
If empirical antibiotic treatment is initiated, Gram-positive
cocci (including methicillin-resistant S. aureus)  and Gram-negative
bacilli (including P. aeruginosa)  must be addressed according to
individual patient risk factors and the institutional ﬂora. Other pos-
sible etiologies, albeit infrequent, have to be considered in special
subsets of patients as those previously treated with antibiotics, with
multiple comorbidities, immune depressed or hospitalized for long
periods of time.63 S. aureus has become an increasingly impactful
etiologic pathogen for bacteremia as it has been shown in several
studies.3,4,64–66 For bacteremia related to central venous catheters,
the etiology is well diversiﬁed.
A reasonable empirical regimen is a combination of daptomycin
and a -lactam active against P. aeruginosa. In patients with -
lactam allergies, aztreonam, an aminoglycoside or a quinolone
could be an alternative. In any case, treatment should follow sen-
sitivity patterns at 24–72 h after cultures are taken67,68 (I-A).
The duration of antibiotic treatment will be related to the iso-
lated pathogen. S. epidermidis can be treated with removal of PVC
if no other inert material that can be colonized and/or infected
exists; duration of treatment should not be longer than 7 days. If
no antibiotic treatment is given, the patient must be symptom-free
and cultures must be negative upon removal of PVC.
A different situation is S. aureus or C. albicans infection as those
require a minimum of 14 days of treatment69 and follow-up cul-
tures at 72 h. Secondary infectious foci like endocarditis and/or
osteomyelitis must be ruled out.70 This is even more important
if bacteremia persists after removal of the PVC thus indicating a
more prolonged presence of bacteria in the blood stream.70–73 This
Consensus Document does not pretend reviewing the treatment of
S. aureus or other bacteremias and the reader is referred to speciﬁc
guidelines.70,71 Gram-negative bacilli infections usually need 7–14
days of treatment after removal of PVC and after the ﬁrst negative
blood culture is conﬁrmed.7
Continuous education
Continuous education of healthcare caregivers on the indica-
tions for PVC insertion and the convenience of having PVC inserted
is necessary. It is necessary to periodically remind the nursing staff
inserting PVC the guidelines for insertion and maintenance74–81
(I-A). Table 3 summarizes the recommendations and degree of evi-
dence and references as produced in this document. The lack of
196 J.A. Capdevila et al. / Cir Cardio
Table 3
Summary of recommendations and degree of evidence and (references) (see - 1).
Always assess the need of inserting a catheter. If necessary,
a central venous line should be preferred over a PVC if
duration of intravenous treatment longer than 6 days or
blood transfusion, parenteral nutrition or chemotherapy.
I-A17,18
If possible, PVC should not be placed in the lower
extremities or at the elbow crease due to higher risk of
phlebitis.
II-A20,21
Insertion of PVC must be performed with the maximum
hygiene with no need for a surgical ﬁeld. There are no
preferences as to which disinfectant solution to use.
I-A9,22,23
An sterile dressing must be used to cover the insertion site
(gauze dressing or transparent semi permeate).
II-A24,25
Adherence to pre-insertion checklist improves prevention
of complication outcomes.
I-A10,31
The need for PVC should be assessed on daily basis. If it is
not necessary, it is advisable to remove the PVC.
II-A18,32,33
The insertion site must be inspected daily. If abnormalities,
malfunction or discomfort at the subcutaneous site, PVC
should be removed.
III-A17,34,35
No antiseptic cream/gel should be used at the insertion
site.
III-C36
Closed connectors to access the PVC can be used; its
external surface must always be decontaminated.
II-A37
Infusion sets can be utilized up to 96 h, exception made of
blood transfusion or lipid emulsions.
I-A38,39
It is mandatory that the nursing ﬁles a daily record of the
PVC.
III-A40
It is not advisable to remove PVC on a routine basis. PVC
should be replaced when clinically indicated.
I-A18,41–51
It is advisable not to keep a PVC in place for over 5 days. III-B
Unused catheters must be removed. II-A10,53,55
When there is suspicion of PVC inserted under suboptimal
conditions, it must be removed.
III-A56,57
If there is suspicion of infection, it is not indicated to use
diagnostic technique leaving the PVC in place.
III-A
If  there is a suspicion of catheter-related infection, the tip
of the PVC must be submitted for Microbiology.
Removed PVC non-suspected to be infected not need
Microbiology.
III-A
Empiric antibiotic treatment of PVC-related bacteremia
has to be deescalated according to microbiology results.
I-A67,68
74–87
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2
2
2
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2
2
2
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2Continuous education in insertion and maintenance
guidelines is an appropriate way to reduce
complications.
I-A
 continuous education program leads to relaxation of the norm,
bandonment of good clinical practices and increase in infection
nd complication rates. On the contrary, speciﬁc educational pro-
rams help in reducing infection rates.82–87 There are different
ays to provide education. Education among peers has shown the
est beneﬁts in guideline follow-up as the staff is engaged in edu-
ation.
It is advisable that the infection and complication rates are peri-
dically disclosed to the staff in charge of inserting PVCs. This
s positive reinforcement on guideline/protocol follow-up and a
arning if deviations occur. Furthermore, the adherence to the
hecklist can be monitored (Table 2).
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